Rational Drug Design of .DELTA. Opioid Receptor Agonist TAN-67

Bibliographic Information

Other Title
  • δオピオイド受容体作動薬,TAN‐67の設計合成
  • デルタ オピオイド ジュヨウタイ サドウヤク TAN 67 ノ セッケイ ゴウセイ

Search this article

Abstract

A selective nonpeptidic δ opioid receptor agonist TAN-67, (4aS*, 12 aR*) -4 a- (3-hydroxyphenyl) -2-methyl-1, 2, 3, 4, 4 a, 5, 12, 12 a-octahydropyrido [3, 4-b] acridine was designed from the selective δ opioid receptor antagonist NTI on the basis of the message-address concept and the accessory site theory. (-) -TAN-67 is a potent and selective δ1 opioid receptor agonist and showed profound antinociceptive effect, cardioprotective effect, and antiarrhythmic effect. On the contrary, (+) -TAN-67 induced hyperalgesia, which is the opposite effect of the antinociception. Optical resolution of racemic TAN-67 and the synthesis of (4aS*, 8 aR*) -4 a- (3-methoxyphenyl) -2-methyl-6-oxodecahydroisoquinoline, the important intermediate ketone of TAN-67 synthesis were also described.

Journal

References(37)*help

See more

Details

Report a problem

Back to top